Story thread · 8 reports / 6 sources
J&J reports phase 2b data on less-frequent lung cancer treatment
seekingalpha.com · 1h
How the coverage leans
Across 6 sources · syndicated copies counted once
First report: Data from Greater Bay Area’s 88 million residents to help improve healthcare policy: GSK — scmp.com, 1d
The coverage
- GSK shares rise as Berenberg upgrades to Buy on stronger drug pipeline
investing.com · 2h
- ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate
medpagetoday.com · 13h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.